All In Biotech

Free tool

FAERS Monitor: Zonisade

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214273 or its brand name (Zonisade, Zonisamide). Reports on generic versions are filed under their own applications.

Reports

10,721

Serious

8,243

77% of reports

Hospitalization

3,294

Death reported

683

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,397
  • seizure1,228
  • off label use819
  • fatigue501
  • somnolence478
  • dizziness402
  • nausea387
  • fall370
  • headache364
  • condition aggravated362
  • drug interaction336
  • vomiting321
  • diarrhoea308
  • epilepsy308
  • convulsion294

Reports by year received

View as table
YearReports
200429
200552
200699
2007115
2008139
2009151
2010165
2011292
2012320
2013240
2014292
2015400
2016544
2017493
2018674
2019816
2020726
2021970
2022968
2023917
2024881
2025856
2026582

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,438 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal1,22821.120.023,336
epilepsySignal30820.017.95,479
convulsionSignal29410.19.12,405
somnolenceSignal4784.74.31,383
drug interactionSignal3364.23.7808
condition aggravatedSignal3622.32.1279
fallSignal3702.22.0239
drug ineffectiveSignal1,3972.12.0835
off label use8191.81.7324
dizziness4021.61.487
vomiting3211.31.228
fatigue5011.31.228
headache3641.11.06
nausea3871.00.91
diarrhoea3080.90.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.